Published in Brain Res Mol Brain Res on November 06, 2003
Delta receptors are required for full inhibitory coupling of mu-receptors to voltage-dependent Ca(2+) channels in dorsal root ganglion neurons. Mol Pharmacol (2009) 0.88
Parkinson's disease, L-DOPA, and endogenous morphine: a revisit. Med Sci Monit (2012) 0.81
Neurobiological Aspects of Mindfulness in Pain Autoregulation: Unexpected Results from a Randomized-Controlled Trial and Possible Implications for Meditation Research. Front Hum Neurosci (2017) 0.75
Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2. J Virol (2000) 2.71
Transcript imaging of the development of human T helper cells using oligonucleotide arrays. Nat Genet (2000) 2.71
A designed metal-binding protein with a novel fold. Nature (1993) 2.48
Molecular crosstalk in host-parasite relationships: schistosome- and leech-host interactions. Parasitol Today (2000) 1.73
Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments. FEBS Lett (1998) 1.55
Cyclophosphamide induces type I interferon and augments the number of CD44(hi) T lymphocytes in mice: implications for strategies of chemoimmunotherapy of cancer. Blood (2000) 1.50
Serpins: an evolutionarily conserved survival strategy. Immunol Today (1999) 1.46
Endogenous morphine is produced in response to cardiopulmonary bypass in neonatal pigs. Acta Anaesthesiol Scand (2000) 1.44
Morphine-mediated alteration of hypertension-related gene expression in human white blood cells and multilineage progenitor cells. J Hum Hypertens (2010) 1.42
Cryopreserved veins in myocardial revascularization: possible mechanism for their increased failure. Ann Thorac Surg (1997) 1.40
Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination. J Immunol (1992) 1.40
A continuous assay of hepatitis C virus protease based on resonance energy transfer depsipeptide substrates. Anal Biochem (1996) 1.40
Downregulation of enkephalin-mediated inflammatory responses by CD10/neutral endopeptidase 24.11. Nature (1990) 1.39
Activity of purified hepatitis C virus protease NS3 on peptide substrates. J Virol (1996) 1.32
A central hydrophobic domain of the hepatitis C virus NS4A protein is necessary and sufficient for the activation of the NS3 protease. J Gen Virol (1996) 1.29
A novel mimetic antigen eliciting protective antibody to Neisseria meningitidis. J Immunol (2001) 1.28
Local anaesthetic activity of beta-caryophyllene. Farmaco (2001) 1.28
Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro. Rheumatology (Oxford) (2006) 1.17
Effect of psychoactive drugs on the output of acetylcholine from the cerebral cortex of the cat. Eur J Pharmacol (1968) 1.15
Investigations into the acetylcholine output from the cerebral cortex of the cat in the presence of hyoscine. Br J Pharmacol Chemother (1967) 1.15
Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide. Brain Res Brain Res Rev (2000) 1.15
A tyrosine-based sorting signal in the beta2 integrin cytoplasmic domain mediates its recycling to the plasma membrane and is required for ligand-supported migration. EMBO J (1999) 1.14
Plasma free and intraplatelet serotonin in patients with Raynaud's phenomenon. Int J Cardiol (1988) 1.12
Probing the tertiary structure of proteins by limited proteolysis and mass spectrometry: the case of Minibody. Protein Sci (1996) 1.11
Natural killer lines and clones with apparent antigen specificity. J Exp Med (1990) 1.10
Reversible antisense inhibition of Shaker-like Kv1.1 potassium channel expression impairs associative memory in mouse and rat. Proc Natl Acad Sci U S A (1997) 1.09
Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage products. Biochemistry (1998) 1.07
Endogenous morphine. Trends Neurosci (2000) 1.07
Interphysician variability in defining the planning target volume in the irradiation of prostate and seminal vesicles. Radiother Oncol (1998) 1.05
Morphine and anandamide stimulate intracellular calcium transients in human arterial endothelial cells: coupling to nitric oxide release. Cell Signal (1999) 1.04
Probing the surface of a sweet protein: NMR study of MNEI with a paramagnetic probe. Protein Sci (2001) 1.02
Estradiol coupling to endothelial nitric oxide stimulates gonadotropin-releasing hormone release from rat median eminence via a membrane receptor. Endocrinology (1999) 1.02
Pharmacokinetic profile of fosfomycin trometamol (Monuril). Eur Urol (1987) 1.02
Local anaesthetic, antibacterial and antifungal properties of sesquiterpenes from myrrh. Planta Med (2000) 1.01
The role of pH, temperature, salt type, and salt concentration on the stability of the crystalline, helical, and randomly coiled forms of collagen. J Biol Chem (1967) 1.01
Substrate specificity of the hepatitis C virus serine protease NS3. J Biol Chem (1997) 1.01
Morphine-induced conformational changes in human monocytes, granulocytes, and endothelial cells and in invertebrate immunocytes and microglia are mediated by nitric oxide. J Immunol (1996) 1.01
Epitope focus, clonal composition and Th1 phenotype of the human CD4 response to the secretory mycobacterial antigen Ag85. Clin Exp Immunol (2001) 1.01
Dup(3)(p2----pter) in two families, including one infant with cyclopia. Am J Med Genet (1985) 1.01
Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis. Arch Virol (1990) 1.01
'Suicide' of crickets harbouring hairworms: a proteomics investigation. Insect Mol Biol (2006) 1.01
Lack of feedback inhibition of insulin secretion in denervated human pancreas. Diabetes (1992) 1.01
Ligands for kappa-opioid and ORL1 receptors identified from a conformationally constrained peptide combinatorial library. J Biol Chem (1999) 1.00
Cytoplasmic nucleoside-triphosphatase similar to axonemal dynein occur widely in different cell types. J Submicrosc Cytol (1983) 1.00
CD31/PECAM-1-driven chemokine-independent transmigration of human T lymphocytes. Eur J Immunol (1996) 0.99
Structural characterization of the interactions of optimized product inhibitors with the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein by NMR and modelling studies. J Mol Biol (1999) 0.99
Sequence homology between HIV gp120, rabies virus glycoprotein, and snake venom neurotoxins. Is the nicotinic acetylcholine receptor an HIV receptor? Arch Virol (1990) 0.99
Anticardiolipin syndrome in childhood: a report of two cases. Clin Exp Rheumatol (1990) 0.99
Study of the bone pathology in early mucolipidosis II (I-cell disease). Eur J Pediatr (1989) 0.98
Surface topology of Minibody by selective chemical modifications and mass spectrometry. Protein Sci (1997) 0.98
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project". Autoimmun Rev (2005) 0.97
Demonstration of two classes of opiate binding sites in the nervous tissue of the marine mollusc Mytilus edulis. Positive homotropic cooperativity of lower affinity binding sites. J Biol Chem (1980) 0.97
Role of muscarinic receptor subtypes in central antinociception. Br J Pharmacol (1992) 0.96
Occurrence of the opiate alkaloid-selective mu3 receptor in mammalian microglia, astrocytes and Kupffer cells. Brain Res (1995) 0.96
Phage display of antibody fragments. Curr Protein Pept Sci (2000) 0.96
An antisense oligonucleotide on the mouse Shaker-like potassium channel Kv1.1 gene prevents antinociception induced by morphine and baclofen. J Pharmacol Exp Ther (1997) 0.96
Continuous infusion of carboplatin during conventional radiotherapy treatment in advanced squamous carcinoma of the cervix uteri IIB-IIIB (UICC). A phase I/II and pharmacokinetic study. Am J Clin Oncol (1997) 0.95
Regulation of lymphocyte traffic by adhesion molecules. Inflamm Res (1999) 0.95
Ketanserin treatment and serotonin in patients with primary and secondary Raynaud's phenomenon. Eur J Clin Pharmacol (1988) 0.95
NMR studies of protein surface accessibility. J Biol Chem (2001) 0.95
Analgesic effects of myrrh. Nature (1996) 0.95
Molecular mimicry between the rabies virus and human immunodeficiency virus. Arch Pathol Lab Med (1995) 0.95
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoiesis: role of hsa-mir-299-5p in CD34+ progenitor cells commitment. Cell Death Dis (2010) 0.95
Investigation into atropine-induced antinociception. Br J Pharmacol (1990) 0.94
IL-10 as a mediator in the HPA axis and brain. J Neuroimmunol (1999) 0.94
Morphine inhibits NF-kappaB nuclear binding in human neutrophils and monocytes by a nitric oxide-dependent mechanism. Anesthesiology (2000) 0.94
Agenesis of corpus callosum, ocular, and skeletal anomalies (X-linked dominant Aicardi's syndrome) in a girl with balanced X/3 translocation. Hum Genet (1982) 0.93
Comparative aspects of opioid-dopamine interaction. Cell Mol Neurobiol (1982) 0.93
Local anaesthetic activity of the essential oil of Lavandula angustifolia. Planta Med (1999) 0.93
Interaction of immunoactive monokines (interleukin 1 and tumor necrosis factor) in the bivalve mollusc Mytilus edulis. Proc Natl Acad Sci U S A (1990) 0.93
Portal vein arterialization in hepatobiliary surgery and liver transplantation. Transplant Proc (2007) 0.93
Antigenicity and immunogenicity of the V3 domain of HIV type 1 glycoprotein 120 expressed on the surface of Streptococcus gordonii. AIDS Res Hum Retroviruses (1999) 0.93
FLASH is essential during early embryogenesis and cooperates with p73 to regulate histone gene transcription. Oncogene (2011) 0.92
Immunosuppression in the definitive and intermediate hosts of the human parasite Schistosoma mansoni by release of immunoactive neuropeptides. Proc Natl Acad Sci U S A (1992) 0.92
The hydrogen method of measuring local blood flow in subcortical structures of the brain: including a comparative study with the 14C antipyrine method. Exp Brain Res (1969) 0.92
Role of histamine in rodent antinociception. Br J Pharmacol (1994) 0.92
Mucolipidosis II: correlation between radiological features and histopathology of the bones. Pediatr Radiol (1989) 0.92
Cerebral abscesses and necrotic cerebral tumours: differential diagnosis by perfusion-weighted magnetic resonance imaging. Radiol Med (2008) 0.91
Hippocampal nitric oxide upregulation precedes memory loss and A beta 1-40 accumulation after chronic brain hypoperfusion in rats. Neurol Res (2003) 0.91
Modular branched neurotensin peptides for tumor target tracing and receptor-mediated therapy: a proof-of-concept. Curr Cancer Drug Targets (2010) 0.91
Isolation and identification of enkephalins in pedal ganglia of Mytilus edulis (Mollusca). Proc Natl Acad Sci U S A (1984) 0.90
Palmitoylethanolamide is a disease-modifying agent in peripheral neuropathy: pain relief and neuroprotection share a PPAR-alpha-mediated mechanism. Mediators Inflamm (2013) 0.90
Effects of physostigmine on brain acetylcholine content and release. Neuropharmacology (1973) 0.90
The effect of oxotremorine on the acetylcholine content of different parts of cat brain. J Pharm Pharmacol (1970) 0.90
Efficient signal transduction by a chimeric yeast-mammalian G protein alpha subunit Gpa1-Gsalpha covalently fused to the yeast receptor Ste2. EMBO J (1997) 0.90
Effect of K+ channel modulation on mouse feeding behaviour. Eur J Pharmacol (1997) 0.90
Human monocyte adhesion is modulated by endothelin B receptor-coupled nitric oxide release. J Immunol (1997) 0.90
Natural analogue peptides of an HIV-1 GP120 T-helper epitope antagonize response of GP120-specific human CD4 T-cell clones. J Acquir Immune Defic Syndr (2000) 0.89
Methylamine and benzylamine induced hypophagia in mice: modulation by semicarbazide-sensitive benzylamine oxidase inhibitors and aODN towards Kv1.1 channels. Br J Pharmacol (2001) 0.89
Local anaesthetic activity of (+)- and (-)-menthol. Planta Med (2001) 0.89
Blockade of clomipramine and amitriptyline analgesia by an antisense oligonucleotide to mKv1.1, a mouse Shaker-like K+ channel. Eur J Pharmacol (1997) 0.89